SIV-1 Nef Activators
SIV-1 Nef Activators encompass a range of chemical compounds that indirectly promote the functional activity of SIV-1 Nef through various intracellular signaling pathways. Curcumin, through its inhibition of NF-κB, enhances SIV-1 Nef's role in viral pathogenicity, similar to its effects on the related HIV-1 Nef protein. PKC activators like Prostratin, Bryostatin 1, Ingenol Mebutate, and PMA significantly contribute to SIV-1 Nef activation by initiating T cell activation and viral replication, processes that are central to SIV-1 Nef's function. SIV-1 Nef activators are a collection of chemical compounds that facilitate the functional activity of SIV-1 Nef indirectly through various cellular signaling mechanisms. Compounds such as Curcumin and Prostratin enhance SIV-1 Nef's functionality by disrupting NF-κB signaling and activating PKC, respectively, both of which are pathways that SIV-1 Nef exploits to augment viral pathogenicity. Bryostatin 1 and Ingenol Mebutate, also PKC activators, further amplify this effect, leading to enhanced T cell activation and viral replication. Forskolin, by raising intracellular cAMP, activates PKA, which has downstream effects on T cell activation, thereby indirectly enhancing SIV-1 Nef's activity.
Additional compounds like JQ1 and SAHA (Vorinostat) alter the host cell's transcriptional landscape in ways that favor Nef-mediated processes. JQ1, a BET bromodomain inhibitor, and SAHA, an HDAC inhibitor, potentially modify transcriptional regulation to enhance pathways that SIV-1 Nef utilizes to increase viral pathogenesis. Bafilomycin A1 disrupts endosomal acidification, affecting receptor trafficking, a cellular process known to be modulated by SIV-1 Nef to promote viral infectivity. C646, by inhibiting histone acetyltransferase, could change the transcriptional control of factors involved in Nef-mediated enhancement of viral infectivity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Prostratin | 60857-08-1 | sc-203422 sc-203422A | 1 mg 5 mg | $141.00 $541.00 | 24 | |
Prostratin activates PKC, which then can enhance SIV-1 Nef activity through the Nef-associated kinase complex, leading to T cell activation which is a key process in the pathogenesis facilitated by Nef proteins. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 is a potent modulator of PKC as well, and by activating this kinase, it can indirectly enhance the activity of SIV-1 Nef in similar pathways as prostratin, notably T cell activation and viral replication. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, leading to the activation of PKA. PKA activation can enhance SIV-1 Nef activity indirectly through downstream effects on T cell activation and viral replication efficiency. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore, raising intracellular calcium levels and potentially enhancing SIV-1 Nef function by activating calcium-dependent signaling pathways that Nef interacts with to modulate T cell function and enhance viral infectivity. | ||||||
Ingenol 3-angelate | 75567-37-2 | sc-364214 sc-364214A | 1 mg 5 mg | $189.00 $734.00 | 3 | |
Ingenol Mebutate activates PKC, which has downstream effects that can amplify the activity of SIV-1 Nef in modulating signaling pathways that are essential for viral replication and spread. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a BET bromodomain inhibitor that can indirectly increase the activity of SIV-1 Nef by altering the host transcriptional environment in a way that favors Nef-mediated enhancement of viral pathogenicity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA is an HDAC inhibitor that can indirectly enhance the activity of SIV-1 Nef by increasing the acetylation of histones, potentially affecting the transcriptional landscapes to favor Nef-related pathways in the host cell. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a V-ATPase inhibitor that can disrupt endosomal acidification and potentially enhance SIV-1 Nef activity by affecting the trafficking and localization of cellular receptors, a process known to be influenced by Nef. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is another PKC activator that can have a profound effect on the activation of signaling pathways, indirectly enhancing SIV-1 Nef functional activity by promoting processes such as T cell activation and viral replication. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a p300/CBP histone acetyltransferase inhibitor, which can indirectly enhance SIV-1 Nef activity by modulating transcription factors and co-activators that participate in Nef-mediated enhancement of viral infectivity. | ||||||